vs
Side-by-side financial comparison of MKS INC (MKSI) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× MKS INC). MKS INC runs the higher net margin — 10.3% vs -13.6%, a 24.0% gap on every dollar of revenue. On growth, MKS INC posted the faster year-over-year revenue change (10.6% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $92.0M). Over the past eight quarters, MKS INC's revenue compounded faster (9.1% CAGR vs -3.6%).
MKS, Inc is a subsidiary of PTC, Inc. It was previously a multinational independent software vendor that was acquired by Parametric Technology Corporation on May 31, 2011. MKS operated in the Application Lifecycle Management (ALM) and Systems Administration market segments.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
MKSI vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.5B |
| Net Profit | $107.0M | $-205.0M |
| Gross Margin | 46.3% | 49.2% |
| Operating Margin | 13.9% | -9.8% |
| Net Margin | 10.3% | -13.6% |
| Revenue YoY | 10.6% | -5.3% |
| Net Profit YoY | 18.9% | -288.1% |
| EPS (diluted) | $1.58 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.5B | ||
| Q3 25 | $988.0M | $1.6B | ||
| Q2 25 | $973.0M | $1.6B | ||
| Q1 25 | $936.0M | $1.5B | ||
| Q4 24 | $935.0M | $1.6B | ||
| Q3 24 | $896.0M | $1.6B | ||
| Q2 24 | $887.0M | $1.6B | ||
| Q1 24 | $868.0M | $1.6B |
| Q4 25 | $107.0M | $-205.0M | ||
| Q3 25 | $74.0M | $160.0M | ||
| Q2 25 | $62.0M | $145.0M | ||
| Q1 25 | $52.0M | $87.0M | ||
| Q4 24 | $90.0M | $109.0M | ||
| Q3 24 | $62.0M | $359.0M | ||
| Q2 24 | $23.0M | $195.0M | ||
| Q1 24 | $15.0M | $201.0M |
| Q4 25 | 46.3% | 49.2% | ||
| Q3 25 | 46.7% | 53.5% | ||
| Q2 25 | 46.6% | 54.8% | ||
| Q1 25 | 47.4% | 55.6% | ||
| Q4 24 | 47.3% | 56.3% | ||
| Q3 24 | 48.2% | 58.3% | ||
| Q2 24 | 47.2% | 58.4% | ||
| Q1 24 | 47.8% | 59.0% |
| Q4 25 | 13.9% | -9.8% | ||
| Q3 25 | 14.0% | 15.2% | ||
| Q2 25 | 13.9% | 14.4% | ||
| Q1 25 | 11.9% | 6.7% | ||
| Q4 24 | 14.7% | 8.1% | ||
| Q3 24 | 14.3% | 13.1% | ||
| Q2 24 | 14.3% | 14.6% | ||
| Q1 24 | 12.2% | 14.5% |
| Q4 25 | 10.3% | -13.6% | ||
| Q3 25 | 7.5% | 10.0% | ||
| Q2 25 | 6.4% | 9.1% | ||
| Q1 25 | 5.6% | 5.8% | ||
| Q4 24 | 9.6% | 6.8% | ||
| Q3 24 | 6.9% | 22.7% | ||
| Q2 24 | 2.6% | 12.1% | ||
| Q1 24 | 1.7% | 12.4% |
| Q4 25 | $1.58 | $-0.78 | ||
| Q3 25 | $1.10 | $0.61 | ||
| Q2 25 | $0.92 | $0.56 | ||
| Q1 25 | $0.77 | $0.33 | ||
| Q4 24 | $1.34 | $0.42 | ||
| Q3 24 | $0.92 | $1.38 | ||
| Q2 24 | $0.33 | $0.75 | ||
| Q1 24 | $0.22 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $418.0M | $574.0M |
| Total DebtLower is stronger | $4.2B | $8.6B |
| Stockholders' EquityBook value | $2.7B | $752.0M |
| Total Assets | $8.8B | $12.9B |
| Debt / EquityLower = less leverage | 1.53× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $418.0M | $574.0M | ||
| Q3 25 | $413.0M | $672.0M | ||
| Q2 25 | $498.0M | $599.0M | ||
| Q1 25 | $407.0M | $547.0M | ||
| Q4 24 | $420.0M | $675.0M | ||
| Q3 24 | $439.0M | $763.0M | ||
| Q2 24 | $506.0M | $704.0M | ||
| Q1 24 | $1.0M | $575.0M |
| Q4 25 | $4.2B | $8.6B | ||
| Q3 25 | $4.3B | $8.8B | ||
| Q2 25 | $4.4B | $8.9B | ||
| Q1 25 | $4.4B | $9.0B | ||
| Q4 24 | $4.5B | $8.9B | ||
| Q3 24 | $4.8B | $8.7B | ||
| Q2 24 | $4.8B | $8.7B | ||
| Q1 24 | $4.7B | $8.7B |
| Q4 25 | $2.7B | $752.0M | ||
| Q3 25 | $2.6B | $906.0M | ||
| Q2 25 | $2.6B | $733.0M | ||
| Q1 25 | $2.4B | $542.0M | ||
| Q4 24 | $2.3B | $472.0M | ||
| Q3 24 | $2.4B | $493.0M | ||
| Q2 24 | $2.2B | $144.0M | ||
| Q1 24 | $2.4B | $48.0M |
| Q4 25 | $8.8B | $12.9B | ||
| Q3 25 | $8.8B | $13.6B | ||
| Q2 25 | $8.8B | $13.5B | ||
| Q1 25 | $8.6B | $13.2B | ||
| Q4 24 | $8.6B | $13.1B | ||
| Q3 24 | $9.0B | $12.8B | ||
| Q2 24 | $8.9B | $12.2B | ||
| Q1 24 | $8.9B | $11.9B |
| Q4 25 | 1.53× | 11.49× | ||
| Q3 25 | 1.64× | 9.74× | ||
| Q2 25 | 1.71× | 12.14× | ||
| Q1 25 | 1.87× | 16.52× | ||
| Q4 24 | 1.93× | 18.81× | ||
| Q3 24 | 1.98× | 17.75× | ||
| Q2 24 | 2.16× | 60.11× | ||
| Q1 24 | 1.94× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.0M | $141.0M |
| Free Cash FlowOCF − Capex | $92.0M | $96.0M |
| FCF MarginFCF / Revenue | 8.9% | 6.4% |
| Capex IntensityCapex / Revenue | 4.8% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $497.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $142.0M | $141.0M | ||
| Q3 25 | $197.0M | $264.0M | ||
| Q2 25 | $165.0M | $220.0M | ||
| Q1 25 | $141.0M | $75.0M | ||
| Q4 24 | $176.0M | $390.0M | ||
| Q3 24 | $163.0M | $141.0M | ||
| Q2 24 | $122.0M | $332.0M | ||
| Q1 24 | $67.0M | $76.0M |
| Q4 25 | $92.0M | $96.0M | ||
| Q3 25 | $146.0M | $218.0M | ||
| Q2 25 | $136.0M | $181.0M | ||
| Q1 25 | $123.0M | $43.0M | ||
| Q4 24 | $125.0M | $335.0M | ||
| Q3 24 | $141.0M | $99.0M | ||
| Q2 24 | $95.0M | $300.0M | ||
| Q1 24 | $49.0M | $30.0M |
| Q4 25 | 8.9% | 6.4% | ||
| Q3 25 | 14.8% | 13.6% | ||
| Q2 25 | 14.0% | 11.4% | ||
| Q1 25 | 13.1% | 2.8% | ||
| Q4 24 | 13.4% | 21.0% | ||
| Q3 24 | 15.7% | 6.3% | ||
| Q2 24 | 10.7% | 18.7% | ||
| Q1 24 | 5.6% | 1.8% |
| Q4 25 | 4.8% | 3.0% | ||
| Q3 25 | 5.2% | 2.9% | ||
| Q2 25 | 3.0% | 2.4% | ||
| Q1 25 | 1.9% | 2.1% | ||
| Q4 24 | 5.5% | 3.5% | ||
| Q3 24 | 2.5% | 2.7% | ||
| Q2 24 | 3.0% | 2.0% | ||
| Q1 24 | 2.1% | 2.8% |
| Q4 25 | 1.33× | — | ||
| Q3 25 | 2.66× | 1.65× | ||
| Q2 25 | 2.66× | 1.52× | ||
| Q1 25 | 2.71× | 0.86× | ||
| Q4 24 | 1.96× | 3.58× | ||
| Q3 24 | 2.63× | 0.39× | ||
| Q2 24 | 5.30× | 1.70× | ||
| Q1 24 | 4.47× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MKSI
| Electronics And Packaging | $303.0M | 29% |
| Specialty Industrial | $295.0M | 29% |
| Photonics Solutions Division | $274.0M | 26% |
| Services | $125.0M | 12% |
| Other | $37.0M | 4% |
OGN
Segment breakdown not available.
